Wells Fargo & Company Seres Therapeutics, Inc. Call Options Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MCRB
# of Institutions
65Shares Held
39.4MCall Options Held
103KPut Options Held
53K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$169 Million6.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$44.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$12.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.62MShares$11.8 Million0.0% of portfolio
-
Ubs Group Ag1.46MShares$10.6 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $906M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...